Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan-Reference-Cited by-同舟云学术

Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan

Published:2019-03 Issue:3 Volume:28 Page:815-820
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Fang Chen-Wen,Tsai Yi-Te,Chou Ping-Chen,Chen Hsi-Ming,Lu Chien-Ming,Tsao Chen-Rong,Chen Chih-Lin,Sun Mu-Chien,Shih Yu-Song,Hsieh Cheng-Yang,Chen Lu-An,Chen Po-Lin,Yeh Jung-Tze,Li Yi-Heng

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery

Reference19 articles.

1. Management of acute stroke in patients taking novel oral anticoagulants;Hankey;Int J Stroke,2014

2. Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation;Hori;Stroke,2013

3. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial;Wong;Stroke,2014

4. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation;Cha;Stroke,2017

5. Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation;Chan;J Am Heart Assoc,2018

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke;Neurology;2024-10-08

2. Intravenous Thrombolysis;Ischemic Stroke Therapeutics;2024

3. Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke — a single centre experience;Neurologia i Neurochirurgia Polska;2023-12-29

4. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta‐Analysis;Journal of the American Heart Association;2023-12-19

5. Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials;Medicina;2023-05-04